Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activation
- 31 December 1987
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 11 (5), 461-468
- https://doi.org/10.1016/0145-2126(87)90078-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Recent approaches to MHC (HLA)-allogeneic bone marrow transplantation without GVHRClinical Immunology Newsletter, 1986
- A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitroBlood, 1985
- Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxinBlood, 1985
- Selective Antilymphocyte Sera (SAL) in Bone Marrow TransplantationInternational Archives of Allergy and Immunology, 1985
- Cobra venom factor: structural homology with the third component of human complement.The Journal of Immunology, 1984
- Anti-T-Cell Reagents for Human Bone Marrow Transplantation: Ricin Linked to Three Monoclonal AntibodiesScience, 1983
- Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complementBlood, 1983
- Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugateNature, 1982
- C3 Shunt Activation in Human Serum Chelated with EGTAThe Journal of Immunology, 1972
- Two Anticomplementary Factors in Cobra Venom: Hemolysis of Guinea Pig Erythrocytes by One of ThemThe Journal of Immunology, 1969